By Mandi Murph Treatment may be changing for patients with Stage III melanoma. Recent clinical trial results show improved outcomes…

By Kim Margolin, M.D., FACP, FASCO   The American Society of Clinical Oncology or ASCO is a professional organization that…

June marks National Cancer Survivor Month, a time to honor the remarkable resilience and strength of those who have battled…

Without intervention today, the number of people affected by melanoma will skyrocket. The World Health Organization warns that new diagnoses…

In this episode, we unlock one of the most challenging aspects of the cancer journey — having difficult conversations. Whether…

Various types of melanoma exist, such as acral, cutaneous, mucosal, and uveal, with additional microscopic subtypes that further divide these…

This Melanoma Awareness Month, we’re shedding light on a statistic that can’t be ignored: 8386 cases of invasive melanoma will…

Surviving cancer or finishing treatment often leaves survivors feeling elated, as if they’ve conquered the world. However, there’s also a…

Replimune Announces Positive Topline Primary Analysis Data by Independent Central Review from IGNYTE Clinical Trial of RP1 plus Nivolumab in…

Here at AIM at Melanoma, we are fortunate to be frequently asked an important question: What are the different ways…